Related Experiment Video
Updated: Jul 18, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer
Lorenzo Cereser1,2, Laura Evangelista3,4, Gianluca Giannarini5
1Institute of Radiology, Department of Medicine, University of Udine, 20072 Milan, Italy.
Abstract:
Over the last years, prostate magnetic resonance imaging (MRI) has gained a key role in the primary diagnosis of clinically significant prostate cancer (csPCa). While a negative MRI can avoid unnecessary prostate biopsies and the overdiagnosis of indolent cancers, a positive examination triggers biopsy samples targeted to suspicious imaging findings, thus increasing the diagnosis of csPCa with a sensitivity and negative predictive value of around 90%. The limitations of MRI, including suboptimal positive predictive values, are fueling debate on how to stratify biopsy decisions and management based on patient risk and how to correctly estimate it with clinical and/or imaging findings. In this setting, "next-generation imaging" imaging based on radiolabeled Prostate-Specific Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is expanding its indications both in the setting of primary staging (intermediate-to-high risk patients) and primary diagnosis (e.g., increasing the sensitivity of MRI or acting as a problem-solving tool for indeterminate MRI cases). This review summarizes the current main evidence on the role of prostate MRI and PSMA-PET as tools for the primary diagnosis of csPCa, and the different possible interaction pathways in this setting.
Insights
Prostate MRI is crucial for diagnosing significant prostate cancer, avoiding biopsies. Next-generation PSMA-PET imaging enhances diagnostic accuracy, especially for complex cases.
Area of Science:
- Urology
- Radiology
- Oncology
Background:
- Prostate magnetic resonance imaging (MRI) is vital for diagnosing clinically significant prostate cancer (csPCa).
- A negative MRI can prevent unnecessary biopsies and overdiagnosis of indolent cancers.
- Limitations in MRI's positive predictive value necessitate improved risk stratification for biopsy decisions.
Purpose of the Study:
- To review the current evidence on prostate MRI for csPCa diagnosis.
- To explore the role of Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) in primary diagnosis and staging.
- To discuss the integration of MRI and PSMA-PET in clinical pathways.
Main Methods:
- Review of current scientific literature on prostate MRI and PSMA-PET.
- Analysis of diagnostic performance metrics (sensitivity, NPV, PPV).
- Evaluation of PSMA-PET's role in primary diagnosis and staging of csPCa.
Main Results:
- Prostate MRI demonstrates high sensitivity and negative predictive value (~90%) for csPCa detection.
- PSMA-PET is emerging as a valuable tool, improving sensitivity and aiding in indeterminate MRI cases.
- PSMA-PET is expanding indications for primary staging in intermediate-to-high risk patients.
Conclusions:
- Both prostate MRI and PSMA-PET are key imaging modalities for csPCa diagnosis.
- Integrating PSMA-PET with MRI can enhance diagnostic accuracy and guide biopsy decisions.
- Further research is needed to optimize the combined use of these technologies for patient management.
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies IV: Magnetic Resonance Imaging
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Magnetic Resonance Imaging

